Literature DB >> 18996699

New jasmonate analogues as potential anti-inflammatory agents.

Hung The Dang1, Hye Ja Lee, Eun Sook Yoo, Jongki Hong, Baoquan Bao, Jae Sue Choi, Jee H Jung.   

Abstract

In an effort to develop new anti-inflammatory agents, methyl jasmonate analogues (2-20) were synthesized and evaluated for their inhibitory effects on the production of pro-inflammatory mediators (NO, IL-6, and TNF-alpha) in lipopolysaccharide (LPS)-activated RAW264.7 murine macrophage cells. The introduction of an enone functionality to the structure of a plant hormone (1) rendered the product (2) a significant anti-inflammatory activity. Analogues further derived from 2 (7, 9, 13, and 15) exhibited even more enhanced activity, and these compounds were much more potent than natural anti-inflammatory prostaglandins (PGA(1), PGA(2), and 15-deoxy-Delta(12,14)-PGJ(2)). Among them, compounds 9 and 15 showed the highest potency, while compounds 7 and 13 would be more desirable with respect to safety. This is the first study demonstrating the anti-inflammatory potential of jasmonate derivatives, and the present results suggest that alpha-haloenone jasmonates (7, 9, 13, and 15) may serve as potential anti-inflammatory leads.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996699     DOI: 10.1016/j.bmc.2008.10.050

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

1.  Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.

Authors:  Akinyinka O Alabi; Abayomi M Ajayi; Benneth Ben-Azu; Osarume Omorobge; Solomon Umukoro
Journal:  Metab Brain Dis       Date:  2019-08-28       Impact factor: 3.584

2.  Antinociceptive effects of methyl jasmonate in experimental animals.

Authors:  Solomon Umukoro; Abimbola S Olugbemide
Journal:  J Nat Med       Date:  2011-03-09       Impact factor: 2.343

3.  Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-κB pathway.

Authors:  Hye-Ja Lee; Kyungah Maeng; Hung-The Dang; Gyeoung-Jin Kang; Chongsuk Ryou; Jee H Jung; Hee-Kyoung Kang; Josef T Prchal; Eun-Sook Yoo; Donghoon Yoon
Journal:  J Mol Med (Berl)       Date:  2010-10-16       Impact factor: 4.599

4.  A Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis.

Authors:  Jieun Choo; Yunna Lee; Xin-Jia Yan; Tae Hwan Noh; Seong Jin Kim; Sujin Son; Charalabos Pothoulakis; Hyung Ryong Moon; Jee H Jung; Eunok Im
Journal:  J Biol Chem       Date:  2015-09-04       Impact factor: 5.157

5.  The In Vitro and In Vivo Anti-Inflammatory Effects of a Phthalimide PPAR-γ Agonist.

Authors:  Mingzhi Su; Jiafu Cao; Jin Huang; Sen Liu; Dong Soon Im; Jin-Wook Yoo; Jee H Jung
Journal:  Mar Drugs       Date:  2017-01-04       Impact factor: 5.118

6.  Anti-Inflammatory and Antioxidant Actions of Methyl Jasmonate Are Associated with Metabolic Modifications in the Liver of Arthritic Rats.

Authors:  Anacharis B Sá-Nakanishi; Jamil Soni-Neto; Lucas S Moreira; Geferson A Gonçalves; Francielli M S Silva; Lívia Bracht; Ciomar A Bersani-Amado; Rosane M Peralta; Adelar Bracht; Jurandir F Comar
Journal:  Oxid Med Cell Longev       Date:  2018-08-23       Impact factor: 6.543

Review 7.  Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes.

Authors:  Iwona Jarocka-Karpowicz; Agnieszka Markowska
Journal:  Molecules       Date:  2021-05-13       Impact factor: 4.411

8.  Suppressive effects of Mimosa pudica (L.) constituents on the production of LPS-induced pro-inflammatory mediators.

Authors:  Neeraj K Patel; Kamlesh K Bhutani
Journal:  EXCLI J       Date:  2014-08-29       Impact factor: 4.068

Review 9.  Methyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosis.

Authors:  Italo Mario Cesari; Erika Carvalho; Mariana Figueiredo Rodrigues; Bruna Dos Santos Mendonça; Nivea Dias Amôedo; Franklin David Rumjanek
Journal:  Int J Cell Biol       Date:  2014-02-06

10.  Novel SIRT1 inhibitor 15-deoxy-Δ12,14-prostaglandin J2 and its derivatives exhibit anticancer activity through apoptotic or autophagic cell death pathways in SKOV3 cells.

Authors:  In Hwan Tae; Eun Young Park; Prasanta Dey; Ji Yeon Son; Seok-Yong Lee; Jee H Jung; Saloni Saloni; Mi-Hyun Kim; Hyung Sik Kim
Journal:  Int J Oncol       Date:  2018-09-13       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.